Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)

Table 5 Perioperative complications ≥grade II per the Clavien-Dindo classification

	SOX arm	mFOLFOX6 arm	Total
	n=53 (%)	n=48 (%)	n=101 (%)
Postoperative hemorrhage
IIIa	0 (0.0)	1 (2.1)	1 (1.0)
Intestinal anastomotic leakage
II	1 (1.9)	1 (2.1)	2 (2.0)
IIIa	1 (1.9)	0 (0.0)	1 (1.0)
IIIb	4 (7.5)	0 (0.0)	4 (4.0)
Intra-abdominal abscess
II	1 (1.9)	0 (0.0)	1 (1.0)
IIIa	3 (5.7)	0 (0.0)	3 (3.0)
IIIb	2 (3.8)	0 (0.0)	2 (2.0)
Wound infection
II	4 (7.5)	1 (2.1)	5 (5.0)
IIIa	2 (3.8)	1 (2.1)	3 (3.0)
Ileus
IIIa	1 (1.9)	2 (4.2)	3 (3.0)
IIIb	1 (1.9)	2 (4.2)	3 (3.0)
Pneumonia
II	0 (0.0)	1 (2.1)	1 (1.0)

ISSN: 1471-2407